Background Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over 30% of the general population and is ...

Meanwhile, AI is reshaping the workplace along with the rest of the world, and you need to be prepared. In an IBM survey of 2 ...

AstraZeneca has turned to another digital health partner to support its aspirations in chronic kidney disease (CKD), joining forces with Aptar to develop algorithms that can be used to detect CKD ...